Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019.


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 25 10 2020
revised: 09 03 2021
accepted: 12 04 2021
pubmed: 25 5 2021
medline: 6 11 2021
entrez: 24 5 2021
Statut: ppublish

Résumé

Between November 2018 and October 2019, carbapenem-resistant Enterobacterales carrying New Delhi Metallo-β-lactamase (NDM) caused one of the largest and persistent outbreaks occurred in Italy and intensified surveillance measures have been taken in all Italian hospitals. In this study we analyzed NDM-5- producing Escherichia coli identified in 2 hospitals of the Lazio region in Italy. Epidemiological and microbiological data demonstrated that in 2018-2019 the NDM-5-producing high-risk E. coli ST167 clone circulated in patients from both hospitals. In 2019, another NDM-5-producing E. coli clone, identified by MLST as ST617 was introduced in one of the 2 hospitals and caused an outbreak. This study describes an application of genomics as a useful method to discern endemic and outbreak clones when applied to strains of the same species (E. coli) with the same resistance determinant (NDM-5) and the relevance of screening patients admitted in critical units for carbapenemase producers to prevent outbreaks.

Identifiants

pubmed: 34030105
pii: S0732-8893(21)00092-4
doi: 10.1016/j.diagmicrobio.2021.115399
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
DNA, Bacterial 0
beta lactamase NDM-5, E coli EC 3.5.2.6
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115399

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Authors have no conflict of interest to declare with respect to the content of this paper

Auteurs

Giulia Bibbolino (G)

Dept. Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.

Federica Maria Di Lella (FM)

Dept. Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.

Alessandra Oliva (A)

Dept. of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Miriam Lichtner (M)

Dept. of Public Health and Infectious Diseases, Sapienza University of Rome, Infectious Disease Unit, SM Goretti Hospital, Latina, Italy.

Cosmo Del Borgo (C)

Infectious Disease Unit, SM Goretti Hospital, Latina, Italy.

Giammarco Raponi (G)

Dept. of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Maria Trancassini (M)

Dept. of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Fabio Mengoni (F)

Dept. of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Gabriele Arcari (G)

Dept. Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Guido Antonelli (G)

Dept. Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Alessandra Carattoli (A)

Dept. Molecular Medicine, Sapienza University of Rome, Rome, Italy. Electronic address: alessandra.carattoli@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH